Stocks · News reference
JP Morgan Maintains Overweight on Kiniksa Pharmaceuticals, Raises Price Target to $107
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 29, 2026, 6:31 PM
- Checked
- Jul 29, 2026, 6:30 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading